The news that the brand is protected from generics for more than a decade "gives AbbVie a kind of tremendous runway," to sell ...

AbbVie (NYSE:ABBV) announced on Thursday that the company has reached settlements with all generic drugmakers to resolve ...

One of the great triumphs of health policy is America’s generic drug market. Nine out of ten U.S. prescriptions are filled with generics. That overwhelming share saves patients and taxpayers hundreds ...

AbbVie has settled with each of the drugmakers that have filed for FDA approval of Rinvoq generics, preventing copycat ...

Penn researchers say they will pursue larger-scale studies to continue testing whether hydroxychloroquine and everolimus can ...

The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.

Rapamycin is an immune suppressant often used in organ transplant patients, but it has also been shown to extend life in ...

A generic formulation of Zeposia will be manufactured and supplied by Netherlands-based Synthon, upon final approval by the ...

While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of a global trade war. While Trump had initially exempted pharmaceuticals from ...

Czech generic drugmaker Zentiva said on Thursday that private equity group Advent International had agreed to sell the ...